AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Melanoma, Melanoma Skin Cancer: Click to Expand ⟱
Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Melanoma, |
A431 |
|
|
|
- |
in-vitro, |
OS, |
MG63 |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
TumCP↓, selectivity↑, AntiCan↑, TumCD↑, Apoptosis↑, Dose↝, ROS↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2780S |
|
|
|
Bacteria↓, antiOx↑, AntiCan↑, eff↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
AntiCan↑, eff↓, ChemoSen↑, ER Stress↑, tumCV↓, DNAdam↑, GSH∅, HSP70/HSPA5↓, UPR↑, β-catenin/ZEB1↓, ROS↑, HO-2↑, SIRT1↑, GlucoseCon∅, lactateProd∅, chemoP↑,
AntiCan↑, eff↓,
AntiCan↑, TumCP↓, Apoptosis↑, TumCCA↑, TumCI↓, p‑p38↓,
AntiCan↑, tumCV↓, PCNA↓, Casp3↑, P21↑, p27/CDKN1B↑, CDK4↓, survivin↓, TumCP↓, Apoptosis↑,
| - |
Review, |
Melanoma, |
RPMI-8226 |
|
|
|
AntiCan↑, TumCP↓, Apoptosis↑, SRC3↓, DIDO1/DIO-1↑, KCNH2/hERG↓, ROS↑, Bcl-2↓, P53↑, cMyc↓, VEGF↓, Casp3↑, cl‑PARP1↑, eff↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
HeLa |
|
|
|
- |
vitro+vivo, |
Melanoma, |
B16-BL6 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
TumCG↓, Ca+2↑, selectivity↑, *Ca+2∅, ROS↑, HSP70/HSPA5↑, AntiCan↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
DIDO1/DIO-1↑, 1, KCNH2/hERG↓, 1, SRC3↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, GSH∅, 1, HO-2↑, 1, ROS↑, 4,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1, GlucoseCon∅, 1, lactateProd∅, 1, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 4, Bcl-2↓, 1, Casp3↑, 2, p27/CDKN1B↑, 1, p‑p38↓, 1, survivin↓, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, HSP70/HSPA5↓, 1, HSP70/HSPA5↑, 1, UPR↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP1↑, 1, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, TumCI↓, 1, TumCP↓, 4, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, eff↓, 3, eff↑, 1, selectivity↑, 2,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 8, chemoP↑, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 44
Pathway results for Effect on Normal Cells:
Migration(tgid=13) ⓘ
Ca+2∅, 1,
Total Targets: 1
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page